Balanced news tone
News Sentiment
GALD sentiment intelligence
Galderma Group AG news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
54
Balanced news tone
9 relevant articles
Price is moving more forcefully than the current news tone suggests.
81/100 classification confidence.
directly relevant articles
high-authority source matches
+6.2% over one week, +10.7% over four weeks, trend active, and near fair-value range.
Evaluating Galderma Group (SWX:GALD) After Dividend Approval And Board Refresh
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
81/100 classification
One-week reaction
6.2%
Price confirming higher
Trend fit
Trend active
10.7% over four weeks
Fair value
11.0%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
5
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Evaluating Galderma Group (SWX:GALD) After Dividend Approval And Board Refresh
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 02 May 2026 07:00
- Source
- simplywall.st
Investing.com
Direct company coverage
Galderma stock rises after reporting strong Q1 sales led by US
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 23 Apr 2026 07:00
- Source
- Investing.com
Market source
Direct company coverage
Assessing Galderma Group (SWX:GALD) Valuation After Recent Share Price Resilience
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Mar 2026 07:00
- Source
- Market source
TradingView
Direct company coverage
Galderma investors sell $6.3 billion of stock in biggest deal of its kind
- Tone
- Negative 34/100
- Event
- Deals and strategy
- Published
- 11 Mar 2026 07:00
- Source
- TradingView
Market source
Direct company coverage
Assessing Galderma Group (SWX:GALD) Valuation After Record 2025 Results And Upgraded Nemluvio Outlook
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 08 Mar 2026 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Is FDA’s RelabotulinumtoxinA Filing Progress Altering The Investment Case For Galderma Group (SWX:GALD)?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- simplywall.st
Market source
Direct company coverage
Is It Too Late to Consider Galderma After Its 61% Surge in 2025?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 09 Dec 2025 08:00
- Source
- Market source
simplywall.st
Direct company coverage
Is Galderma Group (VTX:GALD) A Risky Investment?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Aug 2025 07:00
- Source
- simplywall.st
Market source
Direct company coverage
Individual investors own 13% of Galderma Group AG (VTX:GALD) shares but private equity firms control 58% of the company
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Sep 2024 07:00
- Source
- Market source